SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Jazz Pharmaceuticals announced a definitive agreement to acquire Actio Biosciences for $820 million upfront to acquire ABS-1230, a potential precision...
Sonida Senior Living (SNDA) reported increased occupancy and funds from operations for Q2 2026 while finalizing a $372.5 million amended term loan agr...
Institutional holdings report (13F-HR) filed by ALLIANZ SE....
L.B. Foster reported record second quarter operating cash flow, reduced total debt by 41.2%, and reaffirmed its full year 2026 sales and adjusted EBIT...
GCM Grosvenor reported second quarter 2026 earnings with GAAP net income of $9.6 million and adjusted net income up 22% year-over-year. The firm also ...
Varex Imaging Corp reported Q3 FY26 revenue of $211 million and non-GAAP EPS of $0.31. The company announced the cancellation of its earnings conferen...
The company reported a record $295 million net income for Q2 2026 and announced the largest quarterly dividend in its history, supported by strong liq...
The company reported cash and equivalents of $72.1 million and a decrease in R&D expenses for Q2 2026, driven by completion of zerlasiran Phase 3 read...
Apogee Therapeutics agreed to be acquired by AbbVie for approximately $10.9 billion while also reporting Q2 2026 financial results and positive Phase ...
Institutional holdings report (13F-HR) filed by BLI - Banque de Luxembourg Investments....
Liberty Media announced a proposed private offering of $600M in convertible senior notes with an option for an additional $90M. Net proceeds will be u...
Tenax Therapeutics reports that its Phase 3 LEVEL study for TNX-103 did not meet its primary endpoint, though exploratory analysis showed reduced NT-p...
Tonix Pharmaceuticals announced that TONMYA net sales increased 197% quarter-over-quarter to approximately $11 million. The company also reported appr...
MoonLake Immunotherapeutics reported positive results from its Phase 3 IZAR-1 trial for sonelokimab in psoriatic arthritis, alongside cash runway proj...
Sionna missed the key activity endpoint for the SION-719 proof-of-concept trial, canceling development as an add-on to Trikafta. Despite the setback, ...
Jade Biosciences reported positive Phase 1 data for JADE101 and announced the start of a Phase 2 trial, bolstered by robust cash reserves expected to ...
SIFCO Industries reported net sales of $26.1 million for Q3, up 18.3%, and net income of $4.4 million for the first nine months. The company achieved ...
AAON reported a 101% increase in Q2 net sales to a record $627 million, driven by demand and operational execution. The company raised its full-year 2...
Ceva Inc reported Q2 2026 financial results with total revenue up 13% and licensing revenues up 21%, the highest in three years, driven by demand for ...
News Corp updated its capital management strategy with a repurchase program. This action signals confidence in its financial performance and aims to e...